Endeavor

FDA Approves New Approach to Stem Cell Transplants

Roxanne Laveau’s participation in a clinical trial helped lead to the FDA approval of the Orca-T cell therapy for transplant in patients with blood cancers

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

Next-Gen Cell Therapy Shows Lasting Remission for Older Adults with Aggressive Leukemia

Recently approved obe-cel continues to deliver high remission rates and durable responses in patients once considered too high-risk for immunotherapy

Patient Meets Technologist Who Helped Develop Her Personalized Cancer Therapy

Tiffany Archibong credits the treatment for saving her life

Newly Approved CAR T-Cell Therapy Gives Acute Lymphoblastic Leukemia a New Personalized Option

Novel design and tumor-guided dosing may reduce side effects while maintaining encouraging efficacy

Moffitt Patients Meet Donors at Transplant Reunion

This event celebrated survivorship and coincided with the 35th anniversary of Moffitt's Blood and Marrow Transplant and Cellular Immunotherapy Department

Patient Rides Out Hurricanes Helene and Milton in Hospital

Michael Warren was diagnosed with leukemia just before back-to-back hurricanes hit Florida

One Mother’s Journey Turns into Advocacy Organization to End Drug Shortages

Angels for Change founder Laura Bray shares her story at Moffitt’s Women in Oncology Grand Rounds

Save the Body, Lose the Soul

As a Jehovah’s Witness, Naomi Burgess refuses to accept blood products. When she was diagnosed with leukemia, she faced the ultimate test of her faith.